CCM
ARNA

Copernicus Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Copernicus Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,740
Closed -$287K – 20
2020
Q4 		$287K Buy
+3,740
New +$280K 4.47% 13
2020
Q3 		– Sell
-79,672
Closed -$5.31M – 21
2020
Q2 		$5.01M Buy
79,672
+34,672
+77% +$1.91M 5.5% 10
2020
Q1 		$1.89M Buy
+45,000
New +$2.06M 2.29% 13

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Copernicus Capital Management's ARNA Position: Q1 2021 in Review

Copernicus Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2021, closing a stake of 3,740 shares — an estimated $287K sold.

Copernicus Capital Management first reported a position in ARNA in Q1 2020 and held it in 3 quarters. The position peaked at $5.01M in Q2 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q1 2021.

  • Copernicus Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
  • Copernicus Capital Management sold 3,740 Arena Pharmaceuticals Inc shares in Q1 2021, an estimated $287K.
  • Copernicus Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 3 quarters.
  • Copernicus Capital Management's Arena Pharmaceuticals Inc position peaked at $5.01M in Q2 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2021.

Based on Copernicus Capital Management's 13F filing for Q1 2021, filed 17 May 2021.